-
The debate surrounding the relative merits of abstinence and fidelity vs. condom use (as if the two were mutually exclusive) remains a hotly contested issue, at least in the United States, where it has even spilled over into U.S. international family planning policy.
-
More than two million people living with HIV/AIDS in low and middle income countries now have access to antiretroviral therapy (ART), according to a recent report.
-
Studies in the U.S. estimate that adverse drug events account for up to 28% of emergency department visits and 25% of ambulatory care encounters and that up to 70% of these visits are preventable.
-
FDA recently announced these approvals:
Schwartz Bioscience's Neupro (rotigotine transdermal system), a skin patch designed to treat symptoms of early Parkinson's disease.
-
"Lessons Learned From the Gulf Coast Hurricanes," recently published by the American Health Lawyers Association, looks at legal issues that arose in the context of the 2005 hurricanes.
-
The Seattle hospital that performed growth attenuation treatments and surgery on the severely disabled child known as "Ashley" took place in violation of Washington state law, but the hospital stands behind the ethics and best-interest issues that resulted in the treatment.
-
A recent study suggests that emergency medicine patients may not have a high level of acceptance of the practice of providing an exemption to informed consent for research involving emergency medical settings.
-
'Lights camera:' Bill calls for videotaped surgeries; Medical researchers not as unbiased as they think
-
Colorado Community Health Network policy director Polly Anderson tells State Health Watch that anecdotal information from the 15 plans in the network indicates the study accurately reflects the situation the Colorado plans are experiencing.
-
With an ever-expanding range of hazardous drugs, hospitals must identify employees at risk and conduct medical surveillance at least annually, according to the National Institute for Occupational Safety and Health (NIOSH).